Opportunity Information: Apply for RFA AA 21 011
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH), offered this funding opportunity to support the next phase of the Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD). CIFASD is a long-running, multi-site consortium built to tackle major gaps in the fetal alcohol spectrum disorders (FASD) field by coordinating research across disciplines rather than funding isolated projects. The opportunity is specifically for an Administrative Resource under a U24 Cooperative Agreement, meaning the award is designed to provide centralized leadership, coordination, and shared infrastructure for the broader CIFASD consortium, with substantial NIH involvement in steering and oversight typical of cooperative agreements. Clinical trials are not allowed under this announcement.
The purpose of the CIFASD program, and the reason NIAAA continues to invest in it, is to push progress on several urgent unmet needs in FASD. Those needs include finding ways to identify FASD cases earlier and with better accuracy, improving interventions that can lessen or manage FASD-related outcomes, expanding basic and mechanistic knowledge of alcohol teratogenesis (how prenatal alcohol exposure disrupts development) with an emphasis on faster translation from lab discoveries to practical clinical or public health benefit, and reducing prenatal alcohol exposure overall to lower the incidence of FASD. The expectation is that the consortium structure helps these aims move faster by aligning study designs, sharing data and methods, and coordinating expertise across clinical, translational, and basic science teams.
Because this is the Administrative Resource component, the proposed work would typically focus on the operational backbone of the consortium rather than being a stand-alone hypothesis-driven research project. In practice, an Administrative Resource in a consortium like this generally supports cross-site governance, communication, planning, and coordination; harmonization of protocols and common data elements; facilitation of working groups; monitoring of progress and milestone tracking; organization of meetings and reporting; and consortium-wide data management and sharing processes. The key idea is to enable the scientific projects within CIFASD to function as an integrated program, reduce duplication, and ensure that outputs (data, biospecimens, analytic methods, measures, and findings) are comparable and usable across the network.
Eligibility for the opportunity is broad within the United States and includes many types of organizations that commonly apply for NIH funding. Eligible applicants include state, county, city, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The announcement also highlights that a range of mission-focused and historically underrepresented institution types are included as other eligible applicants, such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, and U.S. territories or possessions.
At the same time, the funding opportunity places clear geographic limitations. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed. In NIH terms, this generally means a U.S.-based applicant can include certain well-justified international collaborations or elements under the rules for foreign components, while still keeping the applicant organization and core award administration within the U.S.
The administrative details in the source data identify the opportunity as RFA AA 21 011, categorized as discretionary funding and using the cooperative agreement funding instrument. The activity category is health, and the CFDA number listed is 93.273. The original closing date was August 16, 2021, and the opportunity was created June 2, 2021. While the source data does not specify an award ceiling or expected number of awards, the main practical takeaway is that the announcement is intended to keep CIFASD functioning as a coordinated national research effort by funding the central administrative and coordinating hub that supports the consortiums integrated science goals.Apply for RFA AA 21 011
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Administrative Resource (U24) (Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
- This funding opportunity was created on 2021-06-02.
- Applicants must submit their applications by 2021-08-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed)
Previous opportunity: Cooperative Agreement for CESU-affiliated Partner with Great Lakes-Northern Forest Cooperative Ecosystem Studies Unit
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AA 21 011
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AA 21 011) also looked into and applied for these:
| Funding Opportunity |
|---|
| Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional) Apply for RFA AA 21 010 Funding Number: RFA AA 21 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Non-Human Primate Developmental Genotype-Tissue Expression (NHP dGTEx) Project (U24 Clinical Trials Not Allowed) Apply for RFA HG 21 026 Funding Number: RFA HG 21 026 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) Apply for RFA RM 21 017 Funding Number: RFA RM 21 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Shared Personal Protective Equipment (PPE) Resources (S10 Clinical Trial Not Allowed) Apply for PAR 21 257 Funding Number: PAR 21 257 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integration, Dissemination, and Evaluation (BRIDGE) Center for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (U54 Clinical Trial Not Allowed) Apply for RFA RM 21 023 Funding Number: RFA RM 21 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Large Research Projects for Prevention of Healthcare-Associated Infections (R01) Apply for PA 21 265 Funding Number: PA 21 265 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| High Resolution Mapping of Biomolecules in Brain Cells in Aging and Alzheimers Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 019 Funding Number: RFA AG 22 019 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Promoting Bunyavirales Basic Science Research (R01 Clinical Trial Not Allowed) Apply for RFA AI 21 046 Funding Number: RFA AI 21 046 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R41/R42 Clinical Trial Optional) Apply for RFA AG 22 014 Funding Number: RFA AG 22 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Mentored Entrepreneurial Career Development Award (K01 Clinical Trial Not Allowed) Apply for RFA AG 22 004 Funding Number: RFA AG 22 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurial Small Business Transition Award (R43/R44 Clinical Trial Optional) Apply for RFA AG 22 007 Funding Number: RFA AG 22 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Research and Entrepreneurial Development Immersion (REDI): Entrepreneurship Enhancement Award (R25 Clinical Trial Not Allowed) Apply for RFA AG 22 003 Funding Number: RFA AG 22 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required) Apply for PAR 21 240 Funding Number: PAR 21 240 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 21 243 Funding Number: PAR 21 243 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required) Apply for PAR 21 242 Funding Number: PAR 21 242 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required) Apply for PAR 21 241 Funding Number: PAR 21 241 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Role of Adaptive Immunity in Etiology of Alzheimers Disease and Alzheimers Disease-Related Dementias (R01 Clinical Trial Optional) Apply for RFA AG 22 017 Funding Number: RFA AG 22 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed) Apply for RFA AG 22 018 Funding Number: RFA AG 22 018 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Disaster Risk Management Apply for 720 663 21 RFI 00007 Funding Number: 720 663 21 RFI 00007 Agency: Ethiopia USAID-Addis Ababa Category: Health Funding Amount: $8,000,000 |
| Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Optional) Apply for PAR 21 250 Funding Number: PAR 21 250 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AA 21 011", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
